Quantification of Pimavanserin in Bulk and Tablet Dosage Form Using A Stability Indicating High Performance Liquid Chromatographic Method

Geetha Bhavani Koduri ^1,2, Hari Babu Bollikolla ³, Ramachandran Dittakavi ³ * , Srinivasu Navuluri ² *

Cited by CrossRef: 5

1- Nassef H, Ahmed H, Bashal A, El-Atawy M, Alanazi T, Mahgoub S, Mohamed M. A novel Six Sigma approach and eco-friendly RP-HPLC technique for determination of pimavanserin and its degraded products: Application of Box–Behnken design. 2024;43(1) [Crossref]

2- Nigović B. New approach on sensitive analysis of pimavanserin, levodopa and entacapone based on synergistic effect of graphene nanoplatelets and graphitized carbon nanotubes in functionalized polymer matrix. Electrochimica Acta. 2023;439:141700 [Crossref]

3- DAMLE M, PARDESHI R, BIDKAR S. DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPTLC METHOD FOR PIMAVANSERIN TARTRATE. Int J Pharm Pharm Sci. 2023;:17 [Crossref]

4- Panda S, Bera R, Mohanty S, Panigrahi S, Sahu B. Analytical procedure development: Concept to application for chemometry based ultrafast LC estimation of pimavanserin in pharmaceuticals. Journal of Liquid Chromatography & Related Technologies. 2020;43(3-4):118 [Crossref]

5- Radić I, Runje M, Babić S. Development of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy. Journal of Pharmaceutical and Biomedical Analysis. 2021;201:114091 [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE